Affimed

12 email addresses found for affimed.com
{last}@affimed.com
12 email addresses
http://affimed.com/investor-relations.php May 5, 2017
http://affimed.com/media.php September 9, 2018
http://biospace.com/article/releases/affimed-therapeutics-ag-receives-eur-2-4-million-3-million-research-grant-from-german-government-to-fund-trispecific-abs- September 9, 2018
http://cnbc.com/2015/05/21/globe-newswire-affimed-reports-financial-results-for-first-quarter-2015.html August 8, 2018
http://cnbc.com/2015/05/29/globe-newswire-affimed-asco-data-demonstrate-consistent-potency-of-nk-cell-engaging-combination-therapy-with-checkpoint-modulators.html August 8, 2018
http://cnbc.com/2015/07/28/globe-newswire-affimed-announces-second-quarter-2015-financial-results-and-corporate-update-conference-call.html August 8, 2018
http://cnbc.com/2015/11/11/globe-newswire-affimed-ceo-to-present-at-the-jefferies-2015-global-healthcare-conference--london.html August 8, 2018
http://cnbc.com/2015/12/01/globe-newswire-affimed-to-present-at-the-oppenheimer-26th-annual-healthcare-conference--new-york.html August 8, 2018
http://crueltyfreeinvesting.org/companies/affimed-n-v August 8, 2018
http://crwepressrelease.com/press-release/10387/affimed-enters-into-collaboration-with-merck-to-evaluate-afm13-in-combination-with-keytrudar-pembrolizumab-for-patients-with-hodgkin-lymphoma September 9, 2018
http://crweworld.com/article/press-releases/11390/affimed-presents-additional-data-on-combination-of-afm13-with-checkpoint-inhibitors-at-ash May 5, 2017
http://crweworld.com/article/press-releases/16054/affimed-enters-into-collaboration-with-merck-to-evaluate-afm13-in-combination-with-keytrudar-pembrolizumab-for-patients-with-hodgkin-lymphoma July 7, 2017
http://crweworld.com/article/press-releases/4603/affimed-announces-significant-investment-by-an-existing-shareholder- May 5, 2017
http://crweworld.com/article/press-releases/9116/affimed-presents-data-on-potency-of-nk-and-t-cell-egfrviii-tandabs-at-sitc March 3, 2017
http://euroinvestor.com/news/2016/01/25/affimed-enters-into-collaboration-with-merck-to-evaluate-afm13-in-combination-with-keytrudar-pembrolizumab-for-patients-with/13310980 January 1, 2017
http://formkit.com/wire/affimed-announces-pricing-public-offering-common-stock January 1, 2017
http://globenewswire.com/news-release/2018/02/01/1330095/0/en/affimed-reports-new-data-for-afm13-from-two-separate-clinical-trials-in-hodgkin-and-cd30-positive-lymphomas.html September 9, 2018
http://globenewswire.com/news-release/2018/02/13/1339579/0/en/affimed-announces-pricing-of-public-offering-of-common-stock.html October 10, 2018
http://inpublic.globenewswire.com/1977937.html May 5, 2017
http://inpublic.globenewswire.com/1980116.html September 9, 2018
http://inpublic.globenewswire.com/1983668.html July 7, 2017
http://inpublic.globenewswire.com/2018/05/18/affimed+announces+annual+general+meeting+of+shareholders+hug2193922.html;jsessionid=pe6ikdbfqblyn9o9r3zmm3hxeqi_n7jze8yvor4eao-ocsjjpoyf!-1441580741 September 9, 2018
http://life-sciences-europe.com/index.php/affimed-appoints-leila-alland-nasdaq-afmd-group-therapeutics-2001-112622.html August 8, 2018
http://life-sciences-europe.com/news/affimed-presents-jefferies-global-nasdaq-afmd-group-therapeutics-2001-106099.html August 8, 2018
http://life-sciences-germany.com/news/affimed-anderson-partner-clinical-nasdaq-afmd-group-therapeutics-2001-109671.html January 1, 2017
http://life-sciences-germany.com/news/affimed-announces-newly-formed-nasdaq-afmd-group-therapeutics-2001-105950.html July 7, 2017
http://life-sciences-germany.com/news/affimed-present-preclinical-data-nasdaq-afmd-group-therapeutics-2001-110042.html March 3, 2017
http://onenewspage.com/n/press+releases/75e3prpxl/affimed-to-present-at-the-cowen-and-company.htm February 2, 2017
http://tmcnet.com/usubmit/2016/11/02/8446510.htm September 9, 2018
http://tmcnet.com/usubmit/2017/09/13/8610909.htm September 9, 2018
http://affimed.com/contact.php October 10, 2018
http://affimed.com/investor-relations.php March 3, 2016
http://affimed.com/media.php August 8, 2017
http://biorn.org/affimed-presents-data-on-afm13-mediated-innateadaptive-immune-crosstalk-at-the-aacr-annual-meeting-2016 May 5, 2016
http://biorn.org/affimed-presents-data-on-egfrwt-and-egfrviii-targeting-nk-and-t-cell-tandabs-at-the-aacr-annual-meeting-2016 May 5, 2016
http://biorn.org/affimed-reports-financial-results-for-first-quarter-2016 September 9, 2016
http://biorn.org/affimed-reports-financial-results-for-fourth-quarter-and-year-end-2015 May 5, 2016
http://biorn.org/affimed-reports-financial-results-for-second-quarter-2016-and-provides-corporate-update September 9, 2016
http://celltribune.com/business/affimed-md-anderson-announce-clinical-immuno-oncology-development-collaboration July 7, 2017
http://cnbc.com/2016/02/04/globe-newswire-affimed-to-present-at-the-leerink-partners-5th-annual-global-healthcare-conference.html September 9, 2018
http://cnbc.com/2016/03/23/globe-newswire-affimed-announces-fourth-quarter-and-year-end-2015-financial-results-and-corporate-update-conference-call.html August 8, 2018
http://cnbc.com/2016/04/21/globe-newswire-affimed-presents-data-on-egfrwt-and-egfrviii-targeting-nk-and-t-cell-tandabs-at-the-aacr-annual-meeting-2016.html November 11, 2017
http://cnbc.com/2016/09/22/globe-newswire-affimed-to-present-at-the-leerink-partners-roundtable-series-rare-disease-immuno-oncology.html August 8, 2018
http://cnbc.com/2017/05/17/globe-newswire-affimed-reports-financial-results-for-first-quarter-2017.html November 11, 2017
http://einpresswire.com/article/395626589/affimed-reports-financial-results-for-second-quarter-2017 October 10, 2017
http://globenewswire.com/news-release/2018/02/01/1330095/0/en/affimed-reports-new-data-for-afm13-from-two-separate-clinical-trials-in-hodgkin-and-cd30-positive-lymphomas.html September 9, 2018
http://globenewswire.com/news-release/2018/02/13/1339579/0/en/affimed-announces-pricing-of-public-offering-of-common-stock.html October 10, 2018
http://inpublic.globenewswire.com/1983668.html July 7, 2017
http://inpublic.globenewswire.com/2018/05/18/affimed+announces+annual+general+meeting+of+shareholders+hug2193922.html;jsessionid=pe6ikdbfqblyn9o9r3zmm3hxeqi_n7jze8yvor4eao-ocsjjpoyf!-1441580741 September 9, 2018
http://life-sciences-europe.com/index.php/affimed-appoints-leila-alland-nasdaq-afmd-group-therapeutics-2001-112622.html August 8, 2018
http://life-sciences-europe.com/news/affimed-announces-proposed-public-nasdaq-afmd-group-therapeutics-2001-109756.html February 2, 2017
http://life-sciences-europe.com/news/affimed-present-leerink-global-nasdaq-afmd-group-therapeutics-2001-107304.html October 10, 2017
http://life-sciences-europe.com/news/affimed-present-preclinical-data-nasdaq-afmd-group-therapeutics-2001-110042.html March 3, 2017
http://life-sciences-europe.com/news/affimed-provides-update-cell-nasdaq-afmd-group-therapeutics-2001-109755.html February 2, 2017
http://life-sciences-germany.com/news/affimed-present-preclinical-data-nasdaq-afmd-group-therapeutics-2001-110042.html March 3, 2017
http://life-sciences-germany.com/news/affimed-presents-new-preclinical-nasdaq-afmd-group-therapeutics-2001-109670.html January 1, 2017
http://onenewspage.com/n/press+releases/75e3prpxl/affimed-to-present-at-the-cowen-and-company.htm February 2, 2017
http://ptcommunity.com/wire/affimed-presents-data-first-class-bcma-targeting-immune-cell-engager-afm26-asco-annual-meeting August 8, 2017
http://thestreet.com/story/13884549/1/affimed-to-present-preclinical-data-on-bi-and-trispecific-immune-cell-engagers-at-ash.html October 10, 2017
http://tmcnet.com/usubmit/2017/09/13/8610909.htm October 10, 2017
http://affimed.com/contact.php October 10, 2015
http://affimed.com/investor-relations.php March 3, 2016
http://biorn.org/affimed-announces-addition-of-dr-andrew-evens-to-scientific-advisory-board May 5, 2016
http://biorn.org/affimed-appoints-dr-joerg-windisch-as-chief-operating-officer-and-adds-dr-bernhard-ehmer-to-supervisory-board May 5, 2016
http://biorn.org/affimed-presents-data-on-afm13-mediated-innateadaptive-immune-crosstalk-at-the-aacr-annual-meeting-2016 May 5, 2016
http://biorn.org/affimed-presents-data-on-egfrwt-and-egfrviii-targeting-nk-and-t-cell-tandabs-at-the-aacr-annual-meeting-2016 May 5, 2016
http://biorn.org/affimed-reports-financial-results-for-fourth-quarter-and-year-end-2015 May 5, 2016
http://celltribune.com/business/affimed-md-anderson-announce-clinical-immuno-oncology-development-collaboration July 7, 2017
http://cnbc.com/2015/05/29/globe-newswire-affimed-asco-data-demonstrate-consistent-potency-of-nk-cell-engaging-combination-therapy-with-checkpoint-modulators.html August 8, 2018
http://cnbc.com/2015/12/01/globe-newswire-affimed-to-present-at-the-oppenheimer-26th-annual-healthcare-conference--new-york.html August 8, 2018
http://cnbc.com/2016/02/04/globe-newswire-affimed-to-present-at-the-leerink-partners-5th-annual-global-healthcare-conference.html September 9, 2018
http://cnbc.com/2016/03/23/globe-newswire-affimed-announces-fourth-quarter-and-year-end-2015-financial-results-and-corporate-update-conference-call.html August 8, 2018
http://cnbc.com/2016/09/22/globe-newswire-affimed-to-present-at-the-leerink-partners-roundtable-series-rare-disease-immuno-oncology.html August 8, 2018
http://crweworld.com/article/press-releases/11390/affimed-presents-additional-data-on-combination-of-afm13-with-checkpoint-inhibitors-at-ash May 5, 2017
http://crweworld.com/article/press-releases/16054/affimed-enters-into-collaboration-with-merck-to-evaluate-afm13-in-combination-with-keytrudar-pembrolizumab-for-patients-with-hodgkin-lymphoma July 7, 2017
http://crweworld.com/article/press-releases/4603/affimed-announces-significant-investment-by-an-existing-shareholder- May 5, 2017
http://crweworld.com/article/press-releases/9116/affimed-presents-data-on-potency-of-nk-and-t-cell-egfrviii-tandabs-at-sitc March 3, 2017
http://formkit.com/wire/affimed-announces-pricing-public-offering-common-stock January 1, 2017
http://inpublic.globenewswire.com/1977937.html May 5, 2017
http://inpublic.globenewswire.com/1980116.html September 9, 2018
http://inpublic.globenewswire.com/1983668.html July 7, 2017
http://life-sciences-france.com/person/audoly-laurent-pierre-fabre-group-persons-people-chief-2001-10647.html June 6, 2016
http://life-sciences-germany.com/news/affimed-anderson-partner-clinical-nasdaq-afmd-group-therapeutics-2001-109671.html January 1, 2017
http://life-sciences-germany.com/news/affimed-announces-newly-formed-nasdaq-afmd-group-therapeutics-2001-105950.html July 7, 2017
http://life-sciences-germany.com/news/affimed-present-preclinical-data-nasdaq-afmd-group-therapeutics-2001-110042.html March 3, 2017
http://life-sciences-germany.com/news/affimed-presents-new-preclinical-nasdaq-afmd-group-therapeutics-2001-109670.html January 1, 2017
http://onenewspage.com/n/press+releases/75e3prpxl/affimed-to-present-at-the-cowen-and-company.htm February 2, 2017
http://technologiepark-heidelberg.de/en/current/news/news-details/article/affimed-appoints-dr-joerg-windisch-as-chief-operating-officer-and-adds-dr-bernhard-ehmer-to-superv October 10, 2016
http://tmcnet.com/usubmit/2016/11/02/8446510.htm November 11, 2016
http://tmcnet.com/usubmit/2017/09/13/8610909.htm September 9, 2018
Show more results
2 more results for affimed.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about affimed.com

Language of the website: English